×
About 4,355 results

ALLMedicine™ Optic Neuritis Center

Research & Reviews  1,308 results

Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorde...
https://doi.org/10.1111/ene.15479
European Journal of Neurology; Dinoto A, Borin GU et. al.

Jun 30th, 2022 - Aquaporin-4 IgG seropositive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD) might occur in association with cancer. According to diagnostic criteria, a probable paraneoplastic NMOSD can be diagnosed only in patients with isolated myelitis...

The Role of OCT Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis ...
https://doi.org/10.1212/WNL.0000000000200883
Neurology Kenney RC, Liu M et. al.

Jun 29th, 2022 - Recent studies have suggested that inter-eye differences (IEDs) in peripapillary retinal nerve fiber layer (pRNFL) or ganglion cell+inner plexiform (GCIPL) thickness by spectral-domain optical coherence tomography (SD-OCT) may identify people with...

Mycotic pseudoaneurysm in the internal carotid artery secondary to cranial base abscess...
https://doi.org/10.1080/02688697.2022.2090503
British Journal of Neurosurgery; Aso D, Fudaba H et. al.

Jun 25th, 2022 - Aspergillus-induced mycotic aneurysm is difficult to treat and often has poor outcomes with severe symptom progression. Early diagnosis is also difficult, and blood and cerebrospinal fluid tests often fail to reveal any findings. A 74-year-old man...

Natural History of Optic Neuritis
https://clinicaltrials.gov/ct2/show/NCT01851434

Jun 24th, 2022 - Objective The goals of this pilot study are: To assess the degree to which subacute changes in clinical, electrophysiological, and imaging measures can robustly predict retinal neuronal loss 12 months after acute optic neuritis. To construct a com...

Longitudinal retinal changes in MOGAD.
https://doi.org/10.1002/ana.26440
Annals of Neurology; Oertel FC, Sotirchos ES et. al.

Jun 16th, 2022 - Patients with myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) suffer from severe optic neuritis (ON) leading to retinal neuro-axonal loss, which can be quantified by optical coherence tomography (OCT). We assessed...

see more →

Guidelines  1 results

EULAR recommendations for the management of systemic lupus erythematosus with neuropsyc...
https://doi.org/10.1136/ard.2010.130476
Annals of the Rheumatic Diseases; Bertsias GK, Ioannidis JP et. al.

Aug 21st, 2010 - To develop recommendations for the diagnosis, prevention and treatment of neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. The authors compiled questions on prevalence and risk factors, diagnosis and monitoring, therapy and pr...

see more →

Drugs  175 results see all →

Clinicaltrials.gov  87 results

Natural History of Optic Neuritis
https://clinicaltrials.gov/ct2/show/NCT01851434

Jun 24th, 2022 - Objective The goals of this pilot study are: To assess the degree to which subacute changes in clinical, electrophysiological, and imaging measures can robustly predict retinal neuronal loss 12 months after acute optic neuritis. To construct a com...

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
https://clinicaltrials.gov/ct2/show/NCT05269667

Jun 9th, 2022 - Neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD) are severe demyelinating inflammatory autoimmune neurological disorders. The estimated global pooled prevalence of NMOSD is 1.82 per 100 000 people (Etemadifar et al. 20...

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
https://clinicaltrials.gov/ct2/show/NCT01623076

May 11th, 2022 - This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to deci...

Ocular Manifestations in Rheumatic Diseases
https://clinicaltrials.gov/ct2/show/NCT03753893

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)
https://clinicaltrials.gov/ct2/show/NCT02850705

Mar 31st, 2022 - Devic's neuromyelitis optica (NMO) is rare. Epidemiological and demographic data are poor, based mainly on monocentric cohorts. Moreover, NMO might be difficult to distinguish from multiple sclerosis and begin with atypical or incomplete clinical ...

see more →

News  165 results

Vision-Threatening Retinal Condition Linked to COVID-19
https://www.medpagetoday.com/ophthalmology/generalophthalmology/98212

Apr 14th, 2022 - COVID-19 infection may be boosting the numbers of a rare ocular condition in which vision is threatened when veins in the retina are blocked, eye specialists in Southern California report. Risk of retinal vein occlusion was higher in the 6 months ...

The struggle for insurance coverage
https://www.mdedge.com/neurology/article/252570/business-medicine/struggle-insurance-coverage
Allan M. Block, MD

Mar 8th, 2022 - Mr. Jones has had multiple sclerosis (MS) since 2008.

Decreased visual acuity and paresthesia
https://www.mdedge.com/multiple-sclerosis-challenge-center/article/250255/multiple-sclerosis/decreased-visual-acuity-and

Dec 27th, 2021 - All of the above conditions can have ophthalmic manifestations, but the majority of optic neuritis cases seen in clinical practice are either sporadic or MS related. Optic neuritis is the first demyelinating event in approximately 20% of patients.

Newly approved drugs offer new hope in NMOSD
https://www.mdedge.com/neurology/article/237024/multiple-sclerosis/newly-approved-drugs-offer-new-hope-nmosd
Randy Dotinga

Mar 10th, 2021 - While they’re extraordinarily expensive, a trio of newly approved medications is providing a variety of effective treatment options for patients with neuromyelitis optica spectrum disorder (NMOSD), a neurologist told colleagues. Dr.

Erythropoietin Falls Short of Neuroprotection in Optic Neuritis
https://www.medscape.com/viewarticle/946851

Mar 4th, 2021 - Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a phase 3 randomized controlled trial. "EPO conve...

see more →

Patient Education  6 results see all →